Shares of Panacea Biotech had been final buying and selling 3.35 per cent decrease at Rs 373 on the BSE.
Share Price of Panacea Biotech declined greater than three per cent on Tuesday, May 18, a day after Seum Insititute’s Adar Poonawalla offloaded his total stake within the agency for Rs 118 crore. According to information on inventory exchanges, Adar Poonawalla offered 31.57 lakh scrips, he held within the agency at a worth of Rs 373.85 per share, taking the full deal worth to Rs 118.02 crore. The shares had been picked by the Serum Institute of India, by way of a separate transaction.
On Tuesday, Panacea Biotech opened on the BSE at Rs 389, swinging to an intra day excessive of Rs 393.15 and an intra day low of Rs 372.50, within the buying and selling session to date. According to dam deal information on BSE, on Monday, May 17, Serum Institute of India (SII) CEO Adar Poonawalla offloaded his total stake in Panacea Biotech amounting to five.15 per cent shareholding of the agency for Rs 118 crore, by way of an open market transaction.
According to the shareholding information for March 2021 quarter, each Adar Poonawalla and Serum Institute of India had been the general public shareholders within the agency and held 5.15 per cent and 4.98 per cent stake in Panacea Biotech, respectively.
On the NSE, Panacea Biotech opened at Rs 390, witnessing an intra day excessive of Rs 392, and an intra day low of Rs 371, within the session to date. It was final buying and selling 3.12 per cent decrease at Rs 373.
Shares of Panacea Biotech had been final buying and selling 3.35 per cent decrease at Rs 373 on the BSE. Pancea Biotech is a world generic and pharmaceutical and vaccine maker registered within the nation.
